CD47 expression on leukemic stem cells (LSCs) predicted worse overall survival of patients with acute myeloid leukemia (AML) and anti-CD47 blocking monoclonal antibodies preferentially enabled phagocytosis of AML leukemic HSCs (20). This evidence concerns the gene CD47 and acute myeloid leukemia.